1
Honbo Toshiyasu, Hata Takehisa, Ishino Akihiro, Tsuji Yoshiharu: Hair revitalizing agent.. Fujisawa Pharmaceutical Co, April 24, 1991: EP0423714-A2 (58 worldwide citation)

A hair revitalizing agent including a compound represented by the formula shown below or a pharmaceutically acceptable salt thereof: (wherein R to R, R to R, X, Y, and n are the same as defined in the present specification).


2
Ueda Yoshio, Hata Takehisa, Yamaguchi Hisami, Ueda Satoshi, Kodani Masateru: Time-controlled explosion systems and processes for preparing the same.. Fujisawa Pharmaceutical Co, February 4, 1987: EP0210540-A1 (24 worldwide citation)

Time-Controlled Explosion Systems comprising drug, swelling agent and water-insoluble coating material characterized in that drug release is caused by the explosion of membrane after a definite time period, and method for preparing it.


3

4
Honbo Toshiyasu, Tanimoto Sachiyo, Yoshida Hiromitsu, Hata Takehisa, Asakura Sotoo, Koyama Yasuto, Kiyota Youhei: Aqueous liquid composition for external use.. Fujisawa Pharmaceutical Co, January 9, 1991: EP0406791-A2 (9 worldwide citation)

An aqueous liquid composition for external use characterized in that the composition contains a tricyclo compound of the formula: wherein the substituents have certain definitions, particularly 17-Allyl-1,14,dihydroxy-12[2-(4-hydroxy-3-methoxycyclohexyl)-1-methylv inyl]-23,2 5-dimethoxy-13,19,21,27- ...


5
Hata Takehisa, Tokunaga Yuji, Shimojo Fumio, Kimura Sumihisa, Hirose Takeo, Ueda Satoshi: Medicinal composition. Fujisawa Pharmaceutical Co, September 22, 1999: EP0943327-A1 (8 worldwide citation)

To provide a pharmaceutical composition comprising a water-insoluble active substance, surfactant(s) and solid carrier(s), which is improved in dissolution and oral absorption characteristics.


6
Hata Takehisa, Kagayama Akira, Kimura Sumihisa, Ueda Satoshi, Murata Saburo: Long-acting pharmaceutical preparation.. Fujisawa Pharmaceutical Co, January 5, 1994: EP0576675-A1 (8 worldwide citation)

A long-acting pharmaceutical preparation comprising a core part containing a drug and a swelling agent and, formed thereon, a coating film containing a biodegradable high-molecular substance, wherein the swelling agent is contained in an amount sufficient to burst the coating film after a given peri ...


7
Kagayama Akira, Tanimoto Sachiyo, Murata Saburo, Hata Takehisa: Lotion. Fujisawa Pharmaceutical Co, January 15, 1997: EP0753297-A1 (3 worldwide citation)

A lotion comprising a tricyclic compounds represented by 17-allyl-1,14-dihydroxy-12-Ä2-(4-hydroxy-3-methoxycyclohexyl)-1-methyl vinylÜ-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-a zatricycloÄ22.3.1.0Üoctacos-18-ene-2,3,10,16-tetrone or a pharmaceutically acceptable salt thereof, a dissolu ...


8
Kagayama Akira Mayumiminami, Tokunaga Yuji Akashiadai Ch, Kaibara Atsunori Teratanicho, Tanimoto Sachiyo Koporasu Miya, Hata Takehisa Kayogaoka: Liposome preparation containing tricyclic compound.. Fujisawa Pharmaceutical Co, June 21, 1995: EP0658344-A1 (3 worldwide citation)

A liposome preparation containing, incorporated in liposome, an immunosuppressive tricyclic compound or a pharmaceutically acceptable salt thereof. Since the tricyclic compound is incorporated in liposome stably and quantitatively, a pharmaceutical preparation with an excellent persistence of drug e ...


9
Hata Takehisa, Kanagawa Nobuto, Morishita Takashi, Suzuki Toshiyuki: Soft capsule.. Fujisawa Pharmaceutical Co, Morishita Jintan Co, April 25, 1984: EP0106202-A2 (2 worldwide citation)

A new type soft capsule is described which comprises wrapping oily substance with film containing water-soluble medicinal substance.


10
Ueda Yoshio, Ibuki Rinta, Kado Kazutake, Ishikuro Hiroshi, Hata Takehisa: Pharmaceutical composition for percutaneous drug absorption and percutaneous drug absorption promoter.. Fujisawa Pharmaceutical Co, December 28, 1988: EP0296553-A2 (1 worldwide citation)

A pharmaceutical composition for percutaneous drug absorption which comprises 5-isopropyl 3-methyl 2-cyano-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxyla te,and ethanol and/or an unsaturated higher fatty acid.